Mannkind Corp

NASDAQ: MNKD
$6.72
-$0.12 (-1.8%)
Closing Price on November 25, 2024

MNKD Articles

The September 29 short interest data have been compared with the previous report, and short interest in the selected biotech stocks was mixed.
The top analyst upgrades, downgrades and other research calls from Tuesday include Alphabet, Check Point Software, Chesapeake Energy, Chevron, Intel, MannKind, Schlumberger and Transocean.
The September 15 short interest data have been compared with the previous report, and short interest in all the selected biotech stocks increased.
The August 31 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks increased.
The August 15 short interest data have been compared with the previous report, and short interest moves in the selected biotech stocks were mixed.
The July 31 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased.
The July 14 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased.
The June 30 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks increased.
The June 15 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks increased.
The May 31 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks increased.
The May 15 short interest data have been compared with the previous report, and moves in the selected biotech stocks were mixed.
The April 28 short interest data have been compared with the previous report, and moves in the selected biotech stocks were mixed.
MannKind Corp. (NASDAQ: MNKD) saw its shares make a massive gain on Monday after it was announced that its One Drop Chrome is now available on Amazon Prime. Overall this is huge of the diabetes...
The April 13 short interest data have been compared with the previous report, and moves in the selected biotech stocks were mixed.
Mattel, Valeant, MannKind, and DryShips all posted new 52-week lows on Friday.